• VER 155008: Unveiling Hsp70 Inhibition in Stress Granule ...

  2025-09-28

  Explore the advanced mechanistic role of VER 155008, a potent HSP 70 inhibitor, in modulating heat shock protein signaling and liquid-liquid phase separation within cancer research. This article uniquely integrates insights from recent phase separation studies and apoptosis assays, offering novel perspectives beyond standard applications.

• Plerixafor (AMD3100): Harnessing CXCR4 Inhibition for Pre...

  2025-09-27

  Explore the advanced scientific applications of Plerixafor (AMD3100), a potent CXCR4 chemokine receptor antagonist, in cancer research and immunology. This article uniquely examines mechanistic insights, comparative efficacy, and future directions for SDF-1/CXCR4 axis inhibition.

• RSL3 and the Ferroptosis Signaling Pathway: Systems Biolo...

  2025-09-26

  Explore how RSL3, a potent glutathione peroxidase 4 inhibitor, drives ferroptosis and ROS-mediated non-apoptotic cell death in cancer biology. This comprehensive article uniquely examines systems-level interactions, synthetic lethality with oncogenic RAS, and integrates recent apoptotic signaling discoveries for a deeper understanding of redox-targeted cancer therapeutics.

• 2'3'-cGAMP (sodium salt): Next-Generation STING Agonist f...

  2025-09-25

  Explore how 2'3'-cGAMP (sodium salt) advances STING-mediated innate immune response research. This article uniquely highlights translational strategies and experimental optimization for immunotherapy and antiviral studies.

• Phosbind Acrylamide: Transforming Phosphorylation Analysi...

  2025-09-24

  Discover how Phosbind Acrylamide revolutionizes protein phosphorylation analysis by enabling precise, antibody-free detection of phosphorylation-dependent mobility shifts in complex signaling pathways. Explore unique mechanistic insights and advanced applications that set this phosphate-binding reagent apart from traditional approaches.

• EZ Cap™ Firefly Luciferase mRNA: Enabling Advanced Biolum...

  2025-09-23

  Explore how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) advances bioluminescent reporter gene assays and mRNA delivery by integrating poly(A) tail mRNA stability, innate immune activation suppression, and Cap 1 mRNA capping structure for optimized research applications.

• Nebivolol Hydrochloride: Selective β1-Adrenoceptor Inhibi...

  2025-09-22

  This article examines Nebivolol hydrochloride as a highly selective β1-adrenoceptor antagonist, highlighting its application in β1-adrenergic receptor

• Biotin-16-UTP: Expanding Capabilities in RNA-Protein Inte...

  2025-09-19

  Biotin-16-UTP, a biotin-labeled uridine triphosphate analog, empowers advanced in vitro transcription RNA labeling for precise RNA detection, purification, and interaction studies. This article examines its unique applications in RNA-protein interaction studies, with a focus on emerging research in lncRNA biology.

• ARCA EGFP mRNA (5-moUTP): Enhancing Reporter mRNA Reliabi...

  2025-09-18

  Explore the scientific advantages of ARCA EGFP mRNA (5-moUTP) as a direct-detection reporter mRNA for fluorescence-based transfection control in mammalian cells, focusing on stability, innate immune suppression, and translational efficiency.

• Given that there are substitutions between

  2025-03-03

  

  Given that there are 132 substitutions between βAnc and the human β subunit, we wondered whether βAnc could replace the human β subunit in hybrid AChRs formed from ancestral and human subunits. We first confirmed that the β subunit is required for expression of human AChRs in HEK293 2272 by co-trans

• Given that there are substitutions between

  2025-03-03

  

  Given that there are 132 substitutions between βAnc and the human β subunit, we wondered whether βAnc could replace the human β subunit in hybrid AChRs formed from ancestral and human subunits. We first confirmed that the β subunit is required for expression of human AChRs in HEK293 Z-Ligustilide sy

• All scientific data over the years points

  2025-03-03

  

  All scientific data over the years points that 5α-reductase inhibitors undoubtedly are an effective treatment for BPH and associated LUTS, having a favorable risk-benefit profile. In contrast, although some studies indicated positive results, there is still no consensus about their use in BPH or PC

• Earlier studies showed that exposure of cells to

  2025-03-01

  

  Earlier studies showed that exposure of cells to IR caused ATM-dependent phosphorylation of 53BP1, as judged by electrophoretic mobility shift [24], [25], [26]. To date, the only known in vivo 53BP1 phosphorylation site(s) are Ser25 and possibly Ser29 [27]. In the course of our studies, we noticed t

• In previous years evidence emerged that inferred secondary m

  2025-03-01

  

  In previous years, evidence emerged that inferred secondary metabolites in plants might exhibit a potential arginase inhibition [36]. In a recent study, Pham and co-workers showed the inhibitory activity of chlorogenic G-1 (7) and piceatannol (8) (Fig. 3b) on mammalian arginase with IC50s of 10.6 a

• We provide here direct evidences that

  2025-03-01

  

  We provide here direct evidences that AT1 receptors are active in ADSCs since Ang II induces intracellular Ca mobilization in these cells. Data obtained during the observation of Ca influxes led us to the search for the ADSCs subpopulation constantly expressing AT1 receptor. ADSCs are necessary for

15591 records 1/1040 page Next 12345 下5页 Last page